How to prepare a solution "Ceftriaxone"

"Ceftriaxone" is administered intravenously or intramuscularly. For dilution of powder will need a pain reliever - "Lidocaine" (1%), and in some cases sterile water for injection. Water for injection use, if necessary, intravenous "Ceftriaxone" or when the patient's allergic reaction to "Lidocaine".

To dissolve 1,0 g "Ceftriaxone", you need to type in a syringe 3.5 ml of 1% solution of "Lidocaine", then on the bottle medicines should be set aside a disk located in the center of the aluminum cap. The rubber stopper should be wiped with a cotton swab dipped in alcohol. After that, the tube is pierced with a syringe, and the vial is introduced a solvent. Then the cure need some time to shake vigorously until the powder is completely dissolved.

In Pediatrics for the treatment of children "Ceftriaxone" is diluted in the following way. First, take out of the water for injection is dissolved in it powder and then put "Lidocaine" in the required quantity (e.g. 3 ml of water for injections you need to take 2 ml anesthetic), then make the shot. The drug solution is injected into the upper part of the buttocks.
Intravenous "Ceftriaxone" should be a nurse.

What you need to know about "Ceftriaxone"

You should know that "Ceftriaxone" and "Lidocaine" can cause allergies, so before applying the means test for sensitivity. For this purpose, on the inner side of the forearm makes little scratches and applied a small amount of the drug, each separately. Hypersensitivity is absent, if after 5-10 minutes on the skin avoid redness. For cultivation "Ceftriaxone" not recommended "Novocaine", as it reduces the effectiveness of the drug and increases the risk of anaphylactic shock.
You cannot mix a solution of "Ceftriaxone" with other antibiotics because of possible crystallization, and increase the risk of allergic reactions.

Do not store the prepared solution "Ceftriaxone" for more than six hours, since this shelf life of the antibiotic is starting to break down, and its effectiveness dramatically reduced. If necessary, use of the drug in lactation at the time of treatment should stop breastfeeding: "Ceftriaxone" enters the mother's milk and may adversely affect the infant (for example, he may develop a goiter).